(Q36622133)

15 August 2017

1 reference

title

Polycystic ovary syndrome in adolescents: current and future treatment options (English)

1 reference

polycystic ovary syndrome

15 August 2017

main subject

1 reference

1 reference

2

Irene Lambrinoudaki

1 reference

15 August 2017

George Mastorakos

1

1 reference

15 August 2017

George Creatsas

series ordinal

3

1 reference

15 August 2017

language of work or name

1 reference

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

311-318

1 reference

https://scigraph.springernature.com/pub.10.2165/00148581-200608050-00004

15 August 2017

exact match

0 references

cites work

A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome

1 reference

12 December 2020

Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate

1 reference

12 December 2020

Polycystic ovary syndrome

1 reference

12 December 2020

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

1 reference

12 December 2020

Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?

1 reference

12 December 2020

Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.

1 reference

12 December 2020

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

1 reference

12 December 2020

Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism

1 reference

12 December 2020

Spironolactone as a single agent for long-term therapy of hirsute patients

1 reference

12 December 2020

Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents

1 reference

12 December 2020

Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin

1 reference

12 December 2020

Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence

1 reference

12 December 2020

Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance

1 reference

12 December 2020

Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial

1 reference

12 December 2020

Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.

1 reference

12 December 2020

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

1 reference

12 December 2020

Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome

1 reference

12 December 2020

Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche

1 reference

12 December 2020

Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome

1 reference

12 December 2020

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

1 reference

12 December 2020

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

12 December 2020

Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.

1 reference

12 December 2020

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism

1 reference

12 December 2020

Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).

1 reference

12 December 2020

Evolution of progestins. Focus on the novel progestin drospirenone

1 reference

12 December 2020

Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease

1 reference

12 December 2020

Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome

1 reference

12 December 2020

Metabolic approaches to the subclassification of polycystic ovary syndrome.

1 reference

12 December 2020

Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.

1 reference

12 December 2020

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

12 December 2020

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

1 reference

12 December 2020

Polycystic ovary syndrome in adolescents

1 reference

12 December 2020

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study

1 reference

12 December 2020

Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome

1 reference

12 December 2020

The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea

1 reference

12 December 2020

Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome

1 reference

12 December 2020

Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.

1 reference

12 December 2020

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovaries--a common finding in normal women

1 reference

12 December 2020

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

1 reference

12 December 2020

Obesity, lipids, cardiovascular risk, and androgen excess

1 reference

12 December 2020

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

1 reference

12 December 2020

Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives

1 reference

12 December 2020

The effect of metformin on hirsutism in polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome.

1 reference

12 December 2020

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

1 reference

12 December 2020

Low-dose flutamide (125 mg/day) as maintenance therapy in the treatment of hirsutism

1 reference

12 December 2020

A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women

1 reference

12 December 2020

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

1 reference

12 December 2020

Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin.

1 reference

12 December 2020

Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity.

1 reference

12 December 2020

Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.

1 reference

12 December 2020

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

12 December 2020

Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone

1 reference

12 December 2020

Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents

1 reference

12 December 2020

Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment

1 reference

12 December 2020

Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial

1 reference

12 December 2020

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

12 December 2020

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

12 December 2020

Cyproterone acetate for severe hirsutism:results of a double-blind dose-ranging study

1 reference

12 December 2020

Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance

1 reference

12 December 2020

Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women

1 reference

12 December 2020

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

1 reference

12 December 2020

Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism

1 reference

12 December 2020

Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system

1 reference

12 December 2020

Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome

1 reference

12 December 2020

Polycystic ovary syndrome in adolescence--a therapeutic conundrum

1 reference

12 December 2020

Obesity and the polycystic ovary syndrome

1 reference

12 December 2020

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

12 December 2020

Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile

1 reference

12 December 2020

Metabolic effects of oral contraceptives in women with polycystic ovary syndrome

1 reference

12 December 2020

An observational study of Yasmin in the management of women with polycystic ovary syndrome

1 reference

12 December 2020

Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome

1 reference

12 December 2020

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

1 reference

12 December 2020

Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.

1 reference

12 December 2020

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

12 December 2020

Selective insulin resistance in the polycystic ovary syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

1 reference

12 December 2020

Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome

1 reference

12 December 2020

Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives

1 reference

12 December 2020

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

1 reference

12 December 2020

Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens

1 reference

12 December 2020

10.2165/00148581-200608050-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1019000846

0 references

1 reference